iSpecimen Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving iSpecimen Inc. now
Current reporting with the operating signal separated from the noise.
iSpecimen Inc.: iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
The story matters when it changes iSpecimen Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.iSpecimen Inc.: iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
The development tests whether iSpecimen Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript
Investors are testing whether iSpecimen Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript
Investors are testing whether iSpecimen Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.One iSpecimen Inc. (NASDAQ:ISPC) Analyst Just Made A Major Cut To Next Year's Estimates
The story matters when it changes iSpecimen Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.iSpecimen Inc. (ISPC) Q4 2022 Earnings Call Transcript
Investors are testing whether iSpecimen Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.iSpecimen Inc. (NASDAQ:ISPC) Analysts Are Cutting Their Estimates: Here's What You Need To Know
The story matters when it changes iSpecimen Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.iSpecimen Inc. (NASDAQ:ISPC) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
The story matters when it changes iSpecimen Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Downgrade: Here's How Analysts See iSpecimen Inc. (NASDAQ:ISPC) Performing In The Near Term
The story matters when it changes iSpecimen Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ISPC filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
iSpecimen Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →